NVAX
Novavax Inc
10.60$
+0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -218.6% | -347.8% | -1,664.0% | -444.9% | -539.0% | -732.1% | -8.9% | 28.2% | -26.0% | -128.3% | -12.8% | -21.8% | |
| 14.4% | 16.5% | 55.4% | 31.5% | 23.8% | 30.4% | 1.0% | 1.1% | 1.8% | 7.4% | 7.1% | 2.5% | |
| 19.9% | 37.1% | 124.8% | 63.5% | 53.4% | 91.4% | 26.9% | 16.0% | 8.1% | 15.3% | 7.1% | 3.2% | |
| 18.0% | 37.6% | 129.9% | 73.1% | 33.5% | 69.6% | 23.5% | 15.4% | 35.9% | – | – | – | |
| 16.7% | 19.9% | -48.7% | 29.2% | -61.7% | -128.7% | 2.5% | 151.2% | -22.6% | -67.7% | 7.1% | -79.0% | |
| 23.7% | 50.4% | 118.6% | 13.4% | 4.0% | 10.0% | 11.5% | 5.0% | 5.8% | 10.6% | 1.9% | 0.5% | |
| -423.5% | -58.7% | 182.5% | 115.4% | 83.4% | 206.3% | -79.4% | 8.7% | -5.8% | -10.6% | -29.9% | -7.0% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | 8.2% | – | – | – | – | – | |
| 361.0% | 576.8% | 24.8% | 207.1% | 299.8% | 527.2% | -8.2% | 51.4% | – | – | – | -0.4% | |
| -2.6% | -2.2% | 2,043.6% | -0.1% | -280.2% | -514.8% | -20.2% | -11.2% | 5.1% | -63.3% | -0.6% | 2.9% | |
| 357.9% | 574.6% | 1,817.4% | 207.0% | 299.8% | 527.2% | 207.1% | 40.3% | 20.3% | 0.8% | 38.2% | 2.5% | |
| -284.2% | 167.6% | 333.8% | -122.0% | -155.9% | 1.2% | 119.1% | 76.7% | -11.2% | -137.5% | -5.6% | -25.7% | |
| -242.3% | -398.3% | -1,782.6% | -458.3% | -543.0% | -742.0% | -20.4% | 23.2% | -31.8% | -138.9% | -14.7% | -22.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.